McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
104.37B
Market cap104.37B
Price-Earnings ratio
23.79
Price-Earnings ratio23.79
Dividend yield
0.37%
Dividend yield0.37%
Average volume
912.73K
Average volume912.73K
High today
$897.46
High today$897.46
Low today
$881.12
Low today$881.12
Open price
$887.30
Open price$887.30
Volume
395.81K
Volume395.81K
52 Week high
$999.00
52 Week high$999.00
52 Week low
$687.68
52 Week low$687.68

Stock Snapshot

As of today, McKesson(MCK) shares are valued at $895.22. The company's market cap stands at 104.37B, with a P/E ratio of 23.79 and a dividend yield of 0.37%.

During the trading session on 2026-09-09, McKesson(MCK) shares reached a daily high of $897.46 and a low of $881.12. At a current price of $895.22, the stock is +1.6% higher than the low and still -0.3% under the high.

Trading activity shows a volume of 395.81K, compared to an average daily volume of 912.73K.

The stock's 52-week range extends from a low of $687.68 to a high of $999.00.

The stock's 52-week range extends from a low of $687.68 to a high of $999.00.

MCK News

MarketWatch 22h
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

...

McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Nasdaq 1d
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates

McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation prioritie...

McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates
Simply Wall St 7d
How Investors Are Reacting To McKesson Portfolio Shift Toward Oncology And Medical-Surgical Spin-Off

In recent months, McKesson completed the sale of its Canadian operations, exited Norway, and announced plans to spin off its Medical-Surgical unit while expandi...

How Investors Are Reacting To McKesson Portfolio Shift Toward Oncology And Medical-Surgical Spin-Off

Analyst ratings

73%

of 22 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.